Cargando…

Targeted therapies for the treatment of non-small-cell lung cancer: Monoclonal antibodies and biological inhibitors

The usual treatments for patients with non-small-cell lung cancer (NSCLC), such as advanced lung adenocarcinoma, are unspecific and aggressive, and include lung resection, radiotherapy and chemotherapy. Recently, treatment with monoclonal antibodies and biological inhibitors has emerged as an effect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Silva, Ana P. S., Coelho, Priscila V., Anazetti, Maristella, Simioni, Patricia U.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2016
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404364/ https://www.ncbi.nlm.nih.gov/pubmed/27831000 http://dx.doi.org/10.1080/21645515.2016.1249551

Ejemplares similares

Targeting carbonic anhydrase IX and XII isoforms with small molecule inhibitors and monoclonal antibodies
por: Kciuk, Mateusz, et al.
Publicado: (2022)

Monoclonal antibodies targeting small airways: a new perspective for biological therapies in severe asthma
por: Lombardi, Carlo, et al.
Publicado: (2022)

Immunotherapy for the treatment of colorectal tumors: focus on approved and in-clinical-trial monoclonal antibodies
por: Françoso, Alex, et al.
Publicado: (2017)

Targeting Tyrosine Kinases in Ovarian Cancer: Small Molecule Inhibitor and Monoclonal Antibody, Where Are We Now?
por: Rendell, Aimee, et al.
Publicado: (2022)

Drug-targeting by monoclonal antibodies.
por: Embleton, M. J.
Publicado: (1987)

Monoclonal antibodies in the detection of bone marrow metastases in small cell lung cancer.
por: Skov, B. G., et al.
Publicado: (1992)

Mutant monoclonal antibodies with alterations in biological functions
por: Yelton, DE, et al.
Publicado: (1982)

Strategies Targeting Type 2 Inflammation: From Monoclonal Antibodies to JAK-Inhibitors
por: Matucci, Andrea, et al.
Publicado: (2021)

Immunotherapy with Monoclonal Antibodies in Lung Cancer of Mice: Oxidative Stress and Other Biological Events
por: Tang, Jun, et al.
Publicado: (2019)

Monoclonal antibody as a targeting mediator for nanoparticle targeted delivery system for lung cancer
por: Wathoni, Nasrul, et al.
Publicado: (2022)

Monoclonal Antibodies Targeting Alarmins: A New Perspective for Biological Therapies of Severe Asthma
por: Pelaia, Corrado, et al.
Publicado: (2021)

Monoclonal antibodies targeting CD20
por: Chang, Chien-Hsing, et al.
Publicado: (2013)

Radioimmunotherapy of transplanted small cell lung cancer with 131I-labelled monoclonal antibody.
por: Yoneda, S., et al.
Publicado: (1988)

The Role of Monoclonal Antibody in Combination with First-Line Chemotherapy in Asian Patients with Advanced Non-Small Cell Lung Cancer
por: Cho, Byoung Chul, et al.
Publicado: (2010)

The use and impact of monoclonal antibody biologics during pregnancy
por: Pham-Huy, Anne, et al.
Publicado: (2021)

Why are CGRP monoclonal antibodies not yet the first line treatment in migraine prevention?
por: Simioni, Caio Vinicius de Meira Grava
Publicado: (2022)

Targeting of phosphatidylserine by monoclonal antibodies enhances activity of immune checkpoint inhibitors in breast tumors
por: Gong, Jian, et al.
Publicado: (2014)

Human monoclonal antibodies to lung-cancer antigens.
por: Sikora, K., et al.
Publicado: (1981)

Human monoclonal antibodies and monoclonal antibody multispecificity.
por: Campbell, A. M., et al.
Publicado: (1987)

Physiologic Changes During Pregnancy and Impact on Small-Molecule Drugs, Biologic (Monoclonal Antibody) Disposition, and Response
por: Eke, Ahizechukwu C., et al.
Publicado: (2023)

Her-2 Targeted Therapy in Advanced Urothelial Cancer: From Monoclonal Antibodies to Antibody-Drug Conjugates
por: Albarrán, Víctor, et al.
Publicado: (2022)

Anti-EGFR monoclonal antibody plus chemotherapy for treating advanced non-small cell lung cancer: A meta-analysis
por: Luo, Wenqing, et al.
Publicado: (2021)

Response to: Monoclonal antibodies targeting CD20
por: Klein, Christian, et al.
Publicado: (2013)

Mer590, a novel monoclonal antibody targeting MER receptor tyrosine kinase, decreases colony formation and increases chemosensitivity in non-small cell lung cancer
por: Cummings, Christopher T., et al.
Publicado: (2014)

Molecular and functional analysis of monoclonal antibodies in support of biologics development
por: Wang, Xin, et al.
Publicado: (2017)

Monoclonal antibodies and small-molecules as distinct subclasses of CCR5-targeted therapies for HIV-1
por: Olson, William C
Publicado: (2006)

Targeting of Tetraspanin CD81 with Monoclonal Antibodies and Small Molecules to Combat Cancers and Viral Diseases
por: Bailly, Christian, et al.
Publicado: (2023)

Combination therapy with anti-ErbB3 monoclonal antibodies and EGFR TKIs potently inhibits Non-small Cell Lung Cancer
por: Noto, Alessia, et al.
Publicado: (2013)

Clinical significance of ≥ 50% PD‐L1 expression with the SP263 monoclonal antibody in non‐small cell lung cancer patients
por: Li, Wenbin, et al.
Publicado: (2018)

Radioimmunoimaging of (125)I-labeled anti-CD93 monoclonal antibodies in a xenograft model of non-small cell lung cancer
por: Liu, Weiwei, et al.
Publicado: (2019)

Bone marrow metastases in small cell lung cancer: detection with magnetic resonance imaging and monoclonal antibodies.
por: Trillet, V., et al.
Publicado: (1989)

PCSK9 Inhibitors: What Lies Beyond Monoclonal Antibodies?
por: EBioMedicine
Publicado: (2015)

Monoclonal Antibody Therapies for Hematological Malignancies: Not Just Lineage-Specific Targets
por: Cuesta-Mateos, Carlos, et al.
Publicado: (2018)

Biological evaluation of antibody-maytansinoid conjugates as a strategy of RON targeted drug delivery for treatment of non-small cell lung cancer
por: Feng, Liang, et al.
Publicado: (2016)

First studies on tumor associated carbonic anhydrases IX and XII monoclonal antibodies conjugated to small molecule inhibitors
por: Testa, Chiara, et al.
Publicado: (2022)

The Biological and Clinical Relevance of Inhibitor of Growth (ING) Genes in Non-Small Cell Lung Cancer
por: Smolle, Elisabeth, et al.
Publicado: (2019)

Preclinical evaluation of racotumomab, an anti-idiotype monoclonal antibody to N-glycolyl-containing gangliosides, with or without chemotherapy in a mouse model of non-small cell lung cancer
por: Segatori, Valeria I., et al.
Publicado: (2012)

Tregalizumab – A Monoclonal Antibody to Target Regulatory T Cells
por: König, Martin, et al.
Publicado: (2016)

Target Therapy in Hematological Malignances: New Monoclonal Antibodies
por: Podhorecka, Monika, et al.
Publicado: (2014)

Binding of omeprazole to protein targets identified by monoclonal antibodies
por: Cartee, Naw May Pearl, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pgnjaj0pq4a2t7okge4k3op5bb